Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $699.80 | 31 | 80.0% |
| Education | $174.98 | 2 | 20.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $143.41 | 3 | $0 (2024) |
| Incyte Corporation | $120.55 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $105.62 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $58.74 | 3 | $0 (2024) |
| PFIZER INC. | $53.31 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $48.38 | 2 | $0 (2024) |
| Genentech USA, Inc. | $48.03 | 2 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $43.99 | 2 | $0 (2024) |
| ABBVIE INC. | $39.25 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $27.08 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $833.55 | 31 | Astellas Pharma US Inc ($143.41) |
| 2023 | $41.23 | 2 | PFIZER INC. ($23.52) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Oncology | ||||||
| 08/22/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/01/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $24.43 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 07/26/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: ANTIFUNGALS | ||||||
| 07/08/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 07/03/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| Category: Hematology/Oncology | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: BioOncology | ||||||
| 06/04/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: BioOncology | ||||||
| 05/15/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $74.99 | General |
| 05/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: HEMATOLOGY | ||||||
| 05/02/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Oncology | ||||||
| 04/30/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Oncology | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Oncology | ||||||
| 04/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $22.18 | General |
| Category: Hematology/Oncology | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Oncology | ||||||
| 04/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Oncology | ||||||
| 03/05/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 02/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Bone Health | ||||||
| 02/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: Oncology | ||||||
About Corah Tillerson, PA
Corah Tillerson, PA is a Hematology & Oncology healthcare provider based in Fishersville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2023. The National Provider Identifier (NPI) number assigned to this provider is 1508551458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Corah Tillerson, PA has received a total of $874.78 in payments from pharmaceutical and medical device companies, with $833.55 received in 2024. These payments were reported across 33 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($699.80).
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical
- Location Fishersville, VA
- Active Since 04/06/2023
- Last Updated 02/03/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1508551458
Products in Payments
- KEYTRUDA (Biological) $58.74
- JAKAFI (Drug) $45.56
- MONOFERRIC (Drug) $43.99
- Xtandi (Drug) $43.42
- KISQALI (Drug) $34.39
- LUTATHERA (Drug) $30.77
- TIVDAK (Biological) $29.79
- CALQUENCE (Drug) $29.33
- Enhertu (Drug) $27.08
- ZEPZELCA (Drug) $25.64
- Rezlidhia (Drug) $24.43
- Tecentriq (Biological) $24.33
- PLUVICTO (Drug) $24.17
- Lenvima (Drug) $23.87
- Columvi (Biological) $23.70
- IBRANCE (Drug) $23.52
- Rezzayo (Drug) $21.69
- VENCLEXTA (Drug) $21.24
- MYRISK (Device) $19.98
- Nubeqa (Drug) $19.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.